Genitourinary Cancer News

Cancer diagnoses fell significantly below expectations in 2020 due to the COVID-19 pandemic but recovered to projected levels the following year, according to results of a cross-sectional study.

Higher omega-3 and omega-6 fatty acid levels may help reduce cancer risk, according to study findings.

Suicide rates for individuals diagnosed with cancer increased over the past 2 decades, according to results of a retrospective study.

A cancer diagnosis may lead to higher risk for psychological or cardiovascular illnesses among a patient’s family members, according to retrospective study results.

Lack of health insurance contributes to a high percentage of racial and ethnic disparities in advanced-stage diagnoses for several cancer types, according to results of a mediation analysis.

Immunotherapy utilization for treatment of advanced kidney or bladder cancers varied by patients’ race or socioeconomic status, according to study results.

Clinical and genetic risk factors can help identify individuals at risk for immune checkpoint inhibitor-induced diabetes, according to results of a cohort study.

Gilead Sciences announced its intention to voluntarily withdraw the accelerated approval for sacituzumab govitecan-hziv for treatment of certain patients with advanced bladder cancer.

Although progress has been made, lack of diversity continues to be problematic in trials of immune checkpoint inhibitors, according to study results.